These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12415691)

  • 1. Relationship of EGFR signal-transduction modulation by tyrosine kinase inhibitors to chemosensitivity and programmed cell death in lung cancer cell lines.
    Lei W; Koty PP; Levitt ML
    Methods Mol Med; 2003; 74():127-43. PubMed ID: 12415691
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s).
    Suarez Pestana E; Greiser U; Sánchez B; Fernández LE; Lage A; Perez R; Böhmer FD
    Br J Cancer; 1997; 75(2):213-20. PubMed ID: 9010029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.
    Rusnak DW; Lackey K; Affleck K; Wood ER; Alligood KJ; Rhodes N; Keith BR; Murray DM; Knight WB; Mullin RJ; Gilmer TM
    Mol Cancer Ther; 2001 Dec; 1(2):85-94. PubMed ID: 12467226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells.
    Lei W; Mayotte JE; Levitt ML
    Anticancer Res; 1999; 19(1A):221-8. PubMed ID: 10226546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells.
    Yu XD; Wang SY; Chen GA; Hou CM; Zhao M; Hong JA; Nguyen DM; Schrump DS
    Cancer J; 2007; 13(2):105-13. PubMed ID: 17476138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of epidermal-growth-factor-receptor-dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro.
    Partik G; Hochegger K; Schörkhuber M; Marian B
    J Cancer Res Clin Oncol; 1999 Jul; 125(7):379-88. PubMed ID: 10394957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors in combinations: will the preclinical promises be kept?
    Bates SE; Piekarz RL
    Cancer J; 2007; 13(2):80-3. PubMed ID: 17476134
    [No Abstract]   [Full Text] [Related]  

  • 8. [EGFR-ERK signaling pathway down-regulates miRNA-145 in lung cancer cells].
    Guo YH; Gao FH; Shi J; Yuan HH; Jiang B
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):187-92. PubMed ID: 23879998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells.
    Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M
    Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor.
    Klein JM; McCarthy TA
    Biochim Biophys Acta; 1997 Mar; 1355(3):218-30. PubMed ID: 9060993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor.
    Mantha AJ; Hanson JE; Goss G; Lagarde AE; Lorimer IA; Dimitroulakos J
    Clin Cancer Res; 2005 Mar; 11(6):2398-407. PubMed ID: 15788691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
    Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
    Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor.
    Peace BE; Hill KJ; Degen SJ; Waltz SE
    Exp Cell Res; 2003 Oct; 289(2):317-25. PubMed ID: 14499632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF-dependent and independent programmed cell death pathways in NCI-H596 nonsmall cell lung cancer cells.
    Lei W; Mayotte JE; Levitt ML
    Biochem Biophys Res Commun; 1998 Apr; 245(3):939-45. PubMed ID: 9588219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor.
    Peavy RD; Chang MS; Sanders-Bush E; Conn PJ
    J Neurosci; 2001 Dec; 21(24):9619-28. PubMed ID: 11739572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells.
    Zhang Y; Yao K; Shi C; Jiang Y; Liu K; Zhao S; Chen H; Reddy K; Zhang C; Chang X; Ryu J; Bode AM; Dong Z; Dong Z
    Oncotarget; 2015 Dec; 6(42):44274-88. PubMed ID: 26517520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.
    Hurbin A; Dubrez L; Coll JL; Favrot MC
    J Biol Chem; 2002 Dec; 277(51):49127-33. PubMed ID: 12356750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells.
    Lee YC; Lee LM; Yang CH; Lin AM; Huang YC; Hsu CC; Chen MS; Chi CW; Yin PH; Kuo CD; Liao JF; Lee HC
    Oncol Rep; 2013 Jan; 29(1):237-43. PubMed ID: 23128522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular movement of green fluorescent protein-tagged phosphatidylinositol 3-kinase in response to growth factor receptor signaling.
    Gillham H; Golding MC; Pepperkok R; Gullick WJ
    J Cell Biol; 1999 Aug; 146(4):869-80. PubMed ID: 10459020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
    Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
    Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.